These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34310956)

  • 1. Freeze-thaw stability of aluminum oxide nanoparticles.
    Trenkenschuh E; Friess W
    Int J Pharm; 2021 Sep; 606():120932. PubMed ID: 34310956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation, process, and storage strategies for lyophilizates of lipophilic nanoparticulate systems established based on the two models paliperidone palmitate and solid lipid nanoparticles.
    Trenkenschuh E; Savšek U; Friess W
    Int J Pharm; 2021 Sep; 606():120929. PubMed ID: 34303819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing the Stabilization Potential of Lyophilization for Extracellular Vesicles.
    Trenkenschuh E; Richter M; Heinrich E; Koch M; Fuhrmann G; Friess W
    Adv Healthc Mater; 2022 Mar; 11(5):e2100538. PubMed ID: 34310074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lyophilization-induced protein denaturation in phosphate buffer systems: monomeric and tetrameric beta-galactosidase.
    Pikal-Cleland KA; Carpenter JF
    J Pharm Sci; 2001 Sep; 90(9):1255-68. PubMed ID: 11745778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping of solution components, pH changes, protein stability and the elimination of protein precipitation during freeze-thawing of fibroblast growth factor 20.
    Maity H; Karkaria C; Davagnino J
    Int J Pharm; 2009 Aug; 378(1-2):122-35. PubMed ID: 19505546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Freeze-drying of nanoparticles: How to overcome colloidal instability by formulation and process optimization.
    Trenkenschuh E; Friess W
    Eur J Pharm Biopharm; 2021 Aug; 165():345-360. PubMed ID: 34052428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of buffer composition and processing conditions on aggregation of bovine IgG during freeze-drying.
    Sarciaux JM; Mansour S; Hageman MJ; Nail SL
    J Pharm Sci; 1999 Dec; 88(12):1354-61. PubMed ID: 10585234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of formulation pH and suspension state on freezing-induced agglomeration of aluminum adjuvants.
    Salnikova MS; Davis H; Mensch C; Celano L; Thiriot DS
    J Pharm Sci; 2012 Mar; 101(3):1050-62. PubMed ID: 22113733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lyophilization and stability of antibody-conjugated mesoporous silica nanoparticle with cationic polymer and PEG for siRNA delivery.
    Ngamcherdtrakul W; Sangvanich T; Reda M; Gu S; Bejan D; Yantasee W
    Int J Nanomedicine; 2018; 13():4015-4027. PubMed ID: 30022824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A method of lyophilizing vaccines containing aluminum salts into a dry powder without causing particle aggregation or decreasing the immunogenicity following reconstitution.
    Li X; Thakkar SG; Ruwona TB; Williams RO; Cui Z
    J Control Release; 2015 Apr; 204():38-50. PubMed ID: 25735896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Freeze drying optimization of polymeric nanoparticles for ocular flurbiprofen delivery: effect of protectant agents and critical process parameters on long-term stability.
    Ramos Yacasi GR; Calpena Campmany AC; Egea Gras MA; Espina García M; García López ML
    Drug Dev Ind Pharm; 2017 Apr; 43(4):637-651. PubMed ID: 28044462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing the acidities of aqueous, frozen, and freeze-dried phosphate buffers: Is there a "pH memory" effect?
    Vetráková Ľ; Vykoukal V; Heger D
    Int J Pharm; 2017 Sep; 530(1-2):316-325. PubMed ID: 28779984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation development of lyophilized, long-term stable siRNA/oligoaminoamide polyplexes.
    Kasper JC; Troiber C; Küchler S; Wagner E; Friess W
    Eur J Pharm Biopharm; 2013 Oct; 85(2):294-305. PubMed ID: 23747745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Freeze-drying of nanosuspensions, 1: freezing rate versus formulation design as critical factors to preserve the original particle size distribution.
    Beirowski J; Inghelbrecht S; Arien A; Gieseler H
    J Pharm Sci; 2011 May; 100(5):1958-68. PubMed ID: 21374626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Freeze drying of nanosuspensions, 2: the role of the critical formulation temperature on stability of drug nanosuspensions and its practical implication on process design.
    Beirowski J; Inghelbrecht S; Arien A; Gieseler H
    J Pharm Sci; 2011 Oct; 100(10):4471-81. PubMed ID: 21607957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of nanocapsules stabilization by amorphous excipients during freeze-drying and storage.
    Abdelwahed W; Degobert G; Fessi H
    Eur J Pharm Biopharm; 2006 Jun; 63(2):87-94. PubMed ID: 16621490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of histidine stabilizing effects on LDH during freeze-drying.
    Al-Hussein A; Gieseler H
    J Pharm Sci; 2013 Mar; 102(3):813-26. PubMed ID: 23280685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cryoprotectants on freezing, lyophilization, and storage of lyophilized recombinant alpha 1-antitrypsin formulations.
    Vemuri S; Yu CD; Roosdorp N
    PDA J Pharm Sci Technol; 1994; 48(5):241-6. PubMed ID: 8000898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of aggregation of aluminum hydroxide adjuvant during freezing and drying.
    Clausi AL; Merkley SA; Carpenter JF; Randolph TW
    J Pharm Sci; 2008 Jun; 97(6):2049-61. PubMed ID: 17879291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of glycine on pH changes and protein stability during freeze-thawing in phosphate buffer systems.
    Pikal-Cleland KA; Cleland JL; Anchordoquy TJ; Carpenter JF
    J Pharm Sci; 2002 Sep; 91(9):1969-79. PubMed ID: 12210044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.